This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Insulin » Inhaled Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

MannKind Inhaled Insulin Matches Injections -Study

Posted: Thursday, September 21, 2006

An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

Inhaled Insulin Coming in September

Posted: Thursday, August 31, 2006

It will be limited at first by the endo’s and then eventually by the family practitioner and internist. So how does it work?

Inhaled Insulin Effective Therapy for Poorly Controlled Type 2 Diabetes

Posted: Thursday, August 17, 2006

Inhaled human insulin (Exubera) is as effective as glibenclamide as adjunctive therapy in patients with type 2 diabetes.

Investigational Januvia (MSD) Put Through Its Paces for Diabetes

Posted: Thursday, June 15, 2006

Researchers reported that, Januvia (sitagliptin), an investigational oral agent for type 2 diabetes, appears to be effective when given as a monotherapy or as an adjunct to Glucophage (metformin) or Actos (pioglitazone). FDA approval expected soon.

Dynamic Duo, Combination Therapy Reverses Type 1 Diabetes

Posted: Monday, May 15, 2006

By combining an oral with an intranasal therapy for type 1 diabetes that have individually shown beneficial, but limited, effects in previous studies, Matthias von Herrath and colleagues at the La Jolla Institute for Allergy and Immunology deliver a one-two punch, and prove that, in this case, 2 treatments work together better than one.

Inhaled Insulin Gets FDA OK

Posted: Thursday, January 26, 2006

Exubera became the first inhaled insulin to get FDA approval.

It will be on pharmacy shelves by the middle of the year, says spokeswoman for Exubera maker Pfizer.

Evidence Supports First Non-Injectable Insulin as Alternative Treatment for Diabetes

Posted: Thursday, December 08, 2005

The article nevertheless concludes that “current evidence suggests that Exubera is an alternative to short-acting subcutaneous insulin therapy providing a further choice for the treatment of patients with type 1 or type 2 diabetes,” and that “a major benefit of Exubera…appears to be the improvement in patient treatment satisfaction which is related to its ease of use, leading to better adherence to treatment.”

Caution: the first week that Exubera is released, you will need to stay off the roads!

Inhaled Insulin a 'Test Case' for FDA

Posted: Monday, September 19, 2005

A regulatory review and approval of a potential blockbuster drug for diabetes is being viewed on Wall Street as a ''test case'' that may reveal whether the Food and Drug Administration has become more cautious about safety.

Update on Inhaled Insulin For Type 2’s

Posted: Monday, August 15, 2005

Inhaled insulin is effective therapy for patients with type 2 diabetes who fail to obtain adequate glycemic control with diet and exercise

The Inhaled Insulin Exubera, Shows Effectiveness in Study

Posted: Tuesday, June 28, 2005

Exubera, an inhaled insulin powder, worked as well in a study of 226 patients as injectable insulin